FindTrial
Sign In

Correlation Analysis Between Akkermansia muciniphila (Akk) Abundance and Colorectal Cancer Development/Treatment Efficacy

Correlation Analysis Between Akkermansia muciniphila (Akk) Abundance and Colorectal Cancer Development/Treatment Efficacy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105842
Enrollment
Unknown
Registered
2025-07-11
Start date
2025-07-20
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

CRC group:NA
Healthy control group:NA

Sponsors

West China Hospital, Sichuan University?
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Experimental Group:?? Patients with pathologically confirmed colorectal cancer (CRC) (treatment-naïve or receiving immunotherapy). ??Control Group:?? Healthy volunteers.

Exclusion criteria

Exclusion criteria: ??Recent medication use??: Antibiotics, probiotics, or immunomodulators within 3 months prior to diagnosis. ??Comorbid conditions??: Concurrent malignancies or severe intestinal diseases (e.g., inflammatory bowel disease [IBD]).

Design outcomes

Primary

MeasureTime frame
Fecal Akkermansia muciniphila abundance;—

Countries

China

Contacts

Public ContactQiu Meng

West China Hospital, Sichuan University?

jiangyuting0701@163.com+86 189 8060 1776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026